Year | Abstract/Paper | Journal | Author(s) Sort descending |
---|---|---|---|
2006 | Carriage of DRB1*13 Is Associated with Increased Posttreatment IgE Levels against Schistosoma mansoni Antigens and Lower Long-Term Reinfection Level. | The Journal of Immunology, 176, 7112-7118. (American Association of Immunologists) |
Booth, M.; Shaw, M.A.; Carpenter, D.; Joseph, S; Kabatereine, N.B.; Kariuki, H.C.; Mwatha, J.K.; Jones, F.M.; Vennervald, B.J.; Ouma, J.H.; Dunne, D.W. |
2004 | Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children. | BMC Infectious Diseases 4:13 doi:10.1186/1471-2334-4-13 (BioMed Central) |
Booth, M.; Vennervald, B.J.; Kenty, L.C.; Butterworth, A.E.; Kariuki, H.C.; Kadzo, H.; Ireri, E.; Amaganga, C.; Kimani, G.; Mwatha, J.K.; Otedo, A.; Ouma, J.H.; Muchiri, E.; Dunne, D.W. |
2005 | AIDS, 19, 1849-1855 (Lippincott Williams & Wilkins (London, United Kingdom)). | Trans R Soc Trop Med Hyg. 99(10), 780-786. (Medline) |
John, C.C.; McHugh, M.M.; Moormann, A.M.; Sumba, P.O.; Ofulla, A.V. |
2004 | Increases in human Th2 cytokine responses to Schistosoma mansoni worm and worm tegument antigens are specifically induced by treatment with Praziquantel. | J Infect Dis 190, 835-842 (Infectious Diseases Society of America) |
Joseph, S.; Jones, F.M.; Walter, K.; Fulford, A.J.C.; Kimani, G.; Mwatha, J.K.; Kamau, T.; Kariuki, C.H.; Kazibwe, F.; Kemijumbi, J.; Kabatereine, N.B.; Ouma, J.H.; Vennervald, B.J.; Dunne, D.W. |
2006 | Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area. | American Journal of Tropical Medicine and Hygiene, 74, 376-385. (American Society of Tropical Medicine and Hygiene) |
Ong’echa, J.M.; Keller, C.C.; Were, T.; Ouma, C.; Otieno, R.O.; Landis-Lewis, Z.; Ochiel, D.O.; Slingluff, J.L.; Ogonji, M.; Orago, A.S.; Vulule. J.M.; Kaplan, S.S.; Day, R.D.; Perkins, D.J. |
2006 | Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: Survival analysis during a nine-year, school-based treatment program. | American Journal of Tropical Medicine and Hygiene, 75, 83-92. (American Society of Tropical Medicine and Hygiene) |
Satayathum, S.A.; Muchiri, E.M.; Ouma, J.H.; Whalen, C.C.; King, CH. |
2004 | Detailed clinical and ultrasound examination of children from a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis. | Trop. Med. Int. Health, 9, 461-470, (Wiley-Blackwell) |
Vennervald, B.J.; Kenty, L.; Butterworth, A.E.; Kariuki, C.H.; Kadzo, H.; Ireri, E.; Amaganga, C.; Kimani, G.; Mwatha, J.K.; Booth, M.; Ouma, J.H.; Dunne, D.W. |
2006 | ncreased human IgE induced by killing Schistosoma mansoni in vivo is associated with pre-treatment Th-2 cytokine responsiveness to worm antigens. | Journal of Immunology. 177, 5490-5498. (American Association of Immunologists) |
Walters, K.; Fulford, AJ.; McBeath, R.; Joseph, S.; Jones, F.M.; Kariuki, C.H.; Mwatha, J.K.; Kimani, G.; Sturrock, R.F.; Kabatereine, N.B.; Kemijumbi, J.; Vennervald, B;J.; Ouma, J.H.; Dunne, D.W. |
2011 | Functional Promoter Haplotypes of Interleukin-18Condition Susceptibility to Severe Malarial Anemia and Childhood Mortality. | Infection and Immunity. 79 (12): 4923-4932. |
Anyona S, Kempaiah P, Raballah E, Ouma C, Were T, Davenport G, Konah S, Vulule J, Hittner J, Gichuki C, Ong'echa J, and Perkins D |
2012 | Functional Promoter Haplotypes of Interleukin-18 Condition Susceptibility to Severe Malarial Anemia and Childhood Mortality. | Infect. Immun., 80, (2) (American Society for Microbiology). |
Anyona, S.B.; Kempaiah, P.; Raballah, E.; Ouma, C.; Were, T.; Davenport, G.C.; Konah, S.N.; Vulule, J.M.; Hittner, J.B.; Gichuki, C.W.; Ong'echa, J.M.; Perkins, D.J. |